View in EDS PDF Full Text

Efficacy of temporally intensified exposure for anxiety disorders: A multicenter randomized clinical trial.

Saved in:
Bibliographic Details
Title: Efficacy of temporally intensified exposure for anxiety disorders: A multicenter randomized clinical trial.
Authors: Pittig, Andre (AUTHOR), Heinig, Ingmar (AUTHOR), Goerigk, Stephan (AUTHOR), Thiel, Freya (AUTHOR), Hummel, Katrin (AUTHOR), Scholl, Lucie (AUTHOR), Deckert, Jürgen (AUTHOR), Pauli, Paul (AUTHOR), Domschke, Katharina (AUTHOR), Lueken, Ulrike (AUTHOR), Fydrich, Thomas (AUTHOR), Fehm, Lydia (AUTHOR), Plag, Jens (AUTHOR), Ströhle, Andreas (AUTHOR), Kircher, Tilo (AUTHOR), Straube, Benjamin (AUTHOR), Rief, Winfried (AUTHOR), Koelkebeck, Katja (AUTHOR), Arolt, Volker (AUTHOR), Dannlowski, Udo (AUTHOR)
Source: Depression & Anxiety (1091-4269). Nov2021, Vol. 38 Issue 11, p1169-1181. 13p. 1 Diagram, 3 Charts, 1 Graph.
Subjects: Anxiety disorders, Clinical trials, Medical personnel, Virtual reality therapy, Exposure therapy, Quality of life
Abstract: Background: The need to optimize exposure treatments for anxiety disorders may be addressed by temporally intensified exposure sessions. Effects on symptom reduction and public health benefits should be examined across different anxiety disorders with comorbid conditions.Methods: This multicenter randomized controlled trial compared two variants of prediction error-based exposure therapy (PeEx) in various anxiety disorders (both 12 sessions + 2 booster sessions, 100 min/session): temporally intensified exposure (PeEx-I) with exposure sessions condensed to 2 weeks (n = 358) and standard nonintensified exposure (PeEx-S) with weekly exposure sessions (n = 368). Primary outcomes were anxiety symptoms (pre, post, and 6-months follow-up). Secondary outcomes were global severity (across sessions), quality of life, disability days, and comorbid depression.Results: Both treatments resulted in substantial improvements at post (PeEx-I: dwithin  = 1.50, PeEx-S: dwithin  = 1.78) and follow-up (PeEx-I: dwithin  = 2.34; PeEx-S: dwithin  = 2.03). Both groups showed formally equivalent symptom reduction at post and follow-up. However, time until response during treatment was 32% shorter in PeEx-I (median = 68 days) than PeEx-S (108 days; TRPeEx-I  = 0.68). Interestingly, drop-out rates were lower during intensified exposure. PeEx-I was also superior in reducing disability days and improving quality of life at follow-up without increasing relapse.Conclusions: Both treatment variants focusing on the transdiagnostic exposure-based violation of threat beliefs were effective in reducing symptom severity and disability in severe anxiety disorders. Temporally intensified exposure resulted in faster treatment response with substantial public health benefits and lower drop-out during the exposure phase, without higher relapse. Clinicians can expect better or at least comparable outcomes when delivering exposure in a temporally intensified manner. [ABSTRACT FROM AUTHOR]
Copyright of Depression & Anxiety (1091-4269) is the property of Wiley-Blackwell and its content may not be copied or emailed to multiple sites without the copyright holder's express written permission. Additionally, content may not be used with any artificial intelligence tools or machine learning technologies. However, users may print, download, or email articles for individual use. This abstract may be abridged. No warranty is given about the accuracy of the copy. Users should refer to the original published version of the material for the full abstract. (Copyright applies to all Abstracts.)
Database: Psychology and Behavioral Sciences Collection
Description
Abstract:<bold>Background: </bold>The need to optimize exposure treatments for anxiety disorders may be addressed by temporally intensified exposure sessions. Effects on symptom reduction and public health benefits should be examined across different anxiety disorders with comorbid conditions.<bold>Methods: </bold>This multicenter randomized controlled trial compared two variants of prediction error-based exposure therapy (PeEx) in various anxiety disorders (both 12 sessions + 2 booster sessions, 100 min/session): temporally intensified exposure (PeEx-I) with exposure sessions condensed to 2 weeks (n = 358) and standard nonintensified exposure (PeEx-S) with weekly exposure sessions (n = 368). Primary outcomes were anxiety symptoms (pre, post, and 6-months follow-up). Secondary outcomes were global severity (across sessions), quality of life, disability days, and comorbid depression.<bold>Results: </bold>Both treatments resulted in substantial improvements at post (PeEx-I: dwithin  = 1.50, PeEx-S: dwithin  = 1.78) and follow-up (PeEx-I: dwithin  = 2.34; PeEx-S: dwithin  = 2.03). Both groups showed formally equivalent symptom reduction at post and follow-up. However, time until response during treatment was 32% shorter in PeEx-I (median = 68 days) than PeEx-S (108 days; TRPeEx-I  = 0.68). Interestingly, drop-out rates were lower during intensified exposure. PeEx-I was also superior in reducing disability days and improving quality of life at follow-up without increasing relapse.<bold>Conclusions: </bold>Both treatment variants focusing on the transdiagnostic exposure-based violation of threat beliefs were effective in reducing symptom severity and disability in severe anxiety disorders. Temporally intensified exposure resulted in faster treatment response with substantial public health benefits and lower drop-out during the exposure phase, without higher relapse. Clinicians can expect better or at least comparable outcomes when delivering exposure in a temporally intensified manner. [ABSTRACT FROM AUTHOR]
ISSN:10914269
DOI:10.1002/da.23204